Daiwa Securities Group Inc. Spectrum Pharmaceuticals Inc Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$3.38 - $5.14 $1,071 - $1,629	-317 Reduced 49.69%	321 $1,000
Q4 2019 Jan 31, 2020	SELL	$3.5 - $10.35 $238 - $703	-68 Reduced 9.63%	638 $2,000
Q1 2019 Apr 26, 2019	BUY	$9.08 - $11.84 $1,362 - $1,776	150 Added 26.98%	706 $8,000
Q1 2018 May 02, 2018	BUY	$16.09 - $23.07 $8,946 - $12,826	556 New	556 $9,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.